Distensibility and pulse wave velocity of the thoracic aorta in patients with juvenile idiopathic arthritis: An MRI study

Clinical and Experimental Rheumatology

Volumn 21, Issue 6, 2003, Pages 794-797

  Argyropoulou, Maria I ^a   Kiortsis, D N ^a   Daskas, N ^a   Xydis, V ^a   Mavridis, A ^b   Efremidis, S C ^a   Siamopoulou, A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b General Hospital G Hatzikostas   (Greece)

Author keywords

Aorta; Athrosclerosis; Distensibility; Juvenile idiopathic arthritis; MRI; Pulse wave velocity

Indexed keywords

CORTICOSTEROID DERIVATIVE; GLUCOSE; HOMOCYSTEINE; INSULIN; LIPID; METHOTREXATE; METHYLPREDNISOLONE; THYROID HORMONE;

ADOLESCENT; ADULT; AORTA ATHEROSCLEROSIS; ARTERY COMPLIANCE; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG EFFICACY; EARLY DIAGNOSIS; ELASTICITY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; JUVENILE RHEUMATOID ARTHRITIS; LIPID BLOOD LEVEL; LOW DRUG DOSE; MALE; METABOLIC PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULSE WAVE; STATISTICAL SIGNIFICANCE; THYROID HORMONE BLOOD LEVEL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AORTA, THORACIC; ARTERIOSCLEROSIS; ARTHRITIS, JUVENILE RHEUMATOID; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; PROBABILITY; PULSATILE FLOW; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; VASCULAR RESISTANCE;

EID: 0346888552     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. del RINCÓN I, WILLIAMS K, STERN MP, FREEMAN GL, ESCALANTE A: High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 2737-45.
2. MEYER O: Atherosclerosis and connective tissue diseases. Joint Bone Spine 2001; 68: 564-75.
3. MANZI S, WASKO MC: Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis 2000; 59: 321-25.
4. CELERMAJER DS, SORENSEN KE, GOOCH VM et al.: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-15.
5. HOPKINS KD, LEHMANN ED, GOSLING RG: Aortic compliance measurments: A non-invasive indicator of atherosclerosis? Lancet 1994; 343: 1447.
6. PITSAVOS C, TOUTOUZAS K, DERNELLIS J et al.: Aortic stiffness in young patients with heterozygous familial hypercholesterolemia. Am Heart J 1998; 135: 604-8.
7. FARRAR DJ, BOND GM, RILEY WA, SAWYER JK: Anatomic correlates of aortic pulse wave velocity and carotid artery elasticity during atherosclerosis progression and regression in monkeys. Circulation 1991; 83: 1754-63.
8. DART AM, LACOMBE F, YEOH JK et al.: Aortic distensibility in patients with isolated hypercholesterolaemia, coronary artery disease, or cardiac transplant. Lancet 1991; 338: 270-73.
9. MOHIADDIN RH, FIRMIN DN, LONGMORE DB: Age-related changes of human aortic flow wave velocity measured non-invasively by magnetic resonance imaging. J Appl Physiol 1993; 74: 492-97.
10. GROENINK M, de ROOS A, MULDER BJ, SPAAN JA, van der WALL EE: Changes in aortic ditensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. Am J Cardiol 1998; 82: 203-8.
11. GROENINK M, de ROOS A, MULDER BJ et al.: Biophysical properties of the normal-sized aorta in patients with Marfan syndrome: Evaluation with MR flow mapping. Radiology 2001; 219: 535-40.
12. STEFANIDIS C, DERNELLIS J, TSIAMIS E et al.: Aortic stiffness as a risk factor for recurrent acute coronary events in patients with ischaemic heart disease. Eur Heart J 2000; 21: 390-6.
13. PETTY RE, SOUTHWOOD TR, BAUM J et al.: Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998; 25: 1991-4.
14. RITCHIE DM, BOYLE JA, McINNES JM et al.: Clinical studies with an articular index for assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968; 147: 393-406.
15. MALLYA RK, MACE BEW: The assessment of disease activity in rheumatoid arthritis using a multivariante analysis. Rheumatol Rehabil 1981; 20:14-17.
16. BAECKLUND E, EKBOM A, SPARÉN P, FELTELIUS N, KLARESKOG L: Disease activity and risk of lymphoma in patients with rheumatoid arthritis: Nested case-control study. BMJ 1998; 317: 180-1
17. FISKERSTRAND T, REFSUM H, KVALHEIM G, UELAND PM: Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 1993; 39: 263-71.
18. KIORTSIS DN, MILIONIS H, BAIRAKTARI E, ELISAF MS: Efficacy of combination of atorvastatin and micronised fenofibrate in the treatment of severe mixed hyperlipidemia. Eur J Clin Pharmacol 2000; 56: 631-5.
19. EPSTEIN FH: Atherosclerosis - An inflammatory disease. N Engl J Med 1999; 340: 115-26.
20. PASCERI V, YEH ETH: A tale of two diseases. Atherosclerosis and rheumatoid arthritis. Circulation 1999; 100: 2124-6.
21. LEADER: Inflammation-mediated rheumatic diseases and atherosclerosis. (Leader) Ann Rheum Dis 2000; 59: 321-5.
22. MOHIADDIN RH, UNDERWOOD HG, BOGREN DN et al.: Regional aortic compliance studied by magnetic resonance imaging: The effects of age, training, and coronary artery disease. Br Heart J 1989; 62: 90-6.
23. LEAROYD BM, TAYLOR MG: Alterations with age in the viscoelastic properties of human arterial wall. Circ Res 1966; 18: 278-92.
24. KOENIG W, SUND M, FROHLICH M et al.: C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237-42.
25. TRACY RP, LEMAITRE RN, PSATY BM: Relationship of C-reactive protein to risk of cardiovascular disease in elderly. Results from the Cardiovascular Health Study and Rural Health Promotion Project. Artherioscler Thromb Vasc Biol 1997; 17: 1121-7.
26. JONSSON SW, BACKMAN C, JOHNSON O et al.: Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 2001; 28: 2597-602.
27. BAKKALOGLU A, KIREL B, OZEN S, SAATCI U, TOPALOGLU, BESBAS N: Plasma lipids and lipoproteins in juvenile chronic arthritis. Clin Rheumatol 1996; 15: 341-5.
28. ILOWITE NT, SAMUEL P, BESELER L, JACOBSON MS: Dyslipoproteinemia in juvenile rheumatoid arthritis. J Pediatr 1989; 114: 823-6.
29. SVENUNGSSON E, JENSEN-URSTAD K, HEIMBÜRGER M, SILVEIRA A, HAMSTEN A, de FAIRE U, WITZTUM JL, FROSTEGARD J: Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001; 104: 1887-93.
30. DUELL PB, MALINOW MR: Homocysteine: an important risk factor for atherosclerotic vascular disease. Curr Opin Lipidol. 1997; 8:28-34.
31. SERIOLO B, FASCIOLO D, SULLI A, CUTOLO M: Homocysteine and antiphosholipid antibodies in rheumatoid arthritis patients: relationships with thrombotic events. Clin Exp Rheumatol 2001; 19: 561-4.
32. LANDEWÉ RB, van den BORNE BE, BREEDVELD FC, DIIJKMANS AC: Methotraxate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet 2000; 355: 1616-7.
33. CHOI HK, HERNÁN MA, SEEGER JD, ROBINS JM, WOLFE F: Methotraxate and mortality in patients with rheumatoid arthritis: A prospective study. Lancet 2002; 359: 1173-7.